Month: June 2020

Dépot Annuel. Veuillez trouver ci-joint le Rapport Annuel 2019 de la Société HiPay. A propos de HiPayHiPay est un prestataire de services de paiement global. En exploitant la puissance des données de paiement, nous participons à la croissance de nos marchands en leur donnant une vision à 360° de leurs activités.HiPay Group est coté sur le compartiment C d’Euronext Paris (code ISIN : FR0012821916 – mnémonique HIPAY).Plus d’informations sur hipay.com retrouvez-nous également sur Twitter et LinkedInContact PresseEmmanuel Chaumeaupress@hipay.comPièce jointeHiPay_Rapport_Annuel_2019_5_01_opt

Orkuveita Reykjavíkur (OR; Reykjavik Energy) will conduct a closed auction of inflation linked green bonds in the series OR020934 GB and OR0180255 GB on June 23rd 2020.OR020934 GB pays a fixed real-interest rate, has a semiannual annuity amortization schedule and a final maturity on September 2nd 2034.OR0180255 GB pays a fixed real-interest rate, has a semiannual annuity amortization schedule and a final maturity on February 18th 2055.Previously issued bonds in the serieses amount to a nominal value of ISK 3,800m in OR020934 GB and 16,111m in OR0180255 GB.The bond offering confirms with approved financing in the form of loans, bonds or bills of Reykjavík Energy for the year 2020.Fossar Markets manage the auction process on behalf of OR and will handle investor relations as well as listing the series on the Nasdaq Iceland Sustainable Bond...

Þriðjudaginn 23. júní 2020 verða boðin til sölu í lokuðu útboði skuldabréf í grænum skuldabréfaflokkum Orkuveitu Reykjavíkur, OR020934 GB og OR180255 GB.OR020934 GB ber fasta verðtryggða vexti og greiðir jafnar greiðslur á sex mánaða fresti með lokagjalddaga 2. september 2034.OR0180255 GB ber fasta verðtryggða vexti og greiðir jafnar greiðslur á sex mánaða fresti með lokagjalddaga 18. febrúar 2055.Áður hafa verið gefin út bréf í flokkunum að nafnvirði 3.800 m.kr. í OR020934 GB og að nafnvirði 16.111 m.kr. í OR0180255 GBÚtgáfa skuldabréfaflokkanna er í samræmi við áður samþykkta lántökuheimild Orkuveitu Reykjavíkur fyrir árið 2020.Fossar markaðir hafa umsjón með útgáfu og sölu skuldabréfanna sem og töku þeirra til viðskipta á Sustainable bond markaði Nasdaq á Íslandi.Nánari upplýsingar:Ingvar Stefánssonframkvæmdastjóri Fjármála ORSími:...

Lanifibranor met the primary endpoint with a statistically significant reduction of the Steatosis Activity Fibrosis score (SAF), which combines assessments of hepatocellular inflammation and ballooning, with no worsening of fibrosis in the Intention To Treat (ITT1) and Per Protocol populations (PP2) Lanifibranor also met key secondary endpoints including NASH resolution with no worsening of fibrosis3 and improvement of liver fibrosis with no worsening of NASH4 in both ITT and PP populations Lanifibranor is the first drug candidate to achieve statistically significant effects on NASH resolution with no worsening of fibrosis and improvement of fibrosis with no worsening of NASH, the FDA and EMA primary endpoints relevant for seeking accelerated approval during future Phase III clinical development   Lanifibranor continued to show a favorable...

 Lanifibranor a atteint le critère principal de l’étude avec une réduction statistiquement significative du score d’activité SAF1, combinant inflammation du foie et « ballooning », sans aggravation de la fibrose dans les populations Intention de Traiter (ITT2) et Per Protocole (PP3)Lanifibranor a également atteint les principaux critères secondaires de l’étude, notamment la résolution de la NASH sans aggravation de la fibrose4 et l’amélioration de la fibrose hépatique sans aggravation de la NASH5 dans les populations ITT et PPLanifibranor est le premier candidat médicament à avoir des effets statistiquement significatifs sur la résolution de la NASH sans aggravation de la fibrose et l’amélioration de la fibrose sans aggravation de la NASH, les principaux critères d’évaluation de la FDA et de l’EMA pour une...

AttachmentVINCIT_15.6_trades

AttachmentGOFORE_15.6_trades

LiiteGOFORE_15.6_trades

LiiteINVEST_15.6_trades